Research Tracker›Biomarker Atlas›PACVS›Anti-idiotype antibodies (ACE2 ↔ Anti-S)

Anti-idiotype antibodies (ACE2 ↔ Anti-S) in PACVS

Anti-idiotype antibodies (ACE2 ↔ Anti-S), also described as Immunopathogenic mechanism, is a autoimmune marker with mixed findings in PACVS (PACVS, PCVS): studies comparing patients with Internal correlation report both increases and decreases. Symptom domains tied to this marker in the source include ACE2 levels correlate with anti-S titers. The finding is drawn from Mantovani et al. 2024; it describes group-level differences, not a threshold that classifies an individual.

↕ InconsistentAutoimmune

Summary

Direction in PACVS↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryAutoimmune
Also described asImmunopathogenic mechanism
Compared againstInternal correlation
Associated symptomsACE2 levels correlate with anti-S titers
Test typeBlood test (serum / plasma / whole blood)
SourceMantovani et al. 2024 — doi:10.3390/biomedicines12122852
Condition atlasPACVS Biomarker Atlas

Related Autoimmune markers in PACVS

Full list: PACVS Biomarker Atlas.

Frequently asked questions

Is Anti-idiotype antibodies (ACE2 ↔ Anti-S) high or low in PACVS?

Mixed. Some studies report higher and others lower Anti-idiotype antibodies (ACE2 ↔ Anti-S) in PACVS compared with Internal correlation, so no single direction is established. Source: Mantovani et al. 2024.

What symptoms is Anti-idiotype antibodies (ACE2 ↔ Anti-S) associated with in PACVS?

The cited literature associates this marker with ACE2 levels correlate with anti-S titers. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Anti-idiotype antibodies (ACE2 ↔ Anti-S)?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Anti-idiotype antibodies (ACE2 ↔ Anti-S) result diagnostic of PACVS?

No. No single biomarker is diagnostic of PACVS. Anti-idiotype antibodies (ACE2 ↔ Anti-S) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Anti-idiotype antibodies (ACE2 ↔ Anti-S) in PACVS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/pacvs/anti-idiotype-antibodies-ace2-anti-s.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.